Janet M. Forst

<i>N</i>-Aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides:  K_ATP Potassium Channel Openers. Modifications on the Western Region

Cyrus J. Ohnmacht, Keith C. Russell, James R. Empfield et al. · Journal of Medicinal Chemistry · 1996 · 26 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Synthesis of 7-chloro-2,3-dihydro-2-[1-(pyridinyl)alkyl]-pyridazino[4,5-b]quinoline-1,4,10(5H)-triones as NMDA glycine-site antagonists

Dean G. Brown, Rebecca A. Urbanek, Thomas M. Bare et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 20 citations

Medicine, Medicinal Chemistry, Pharmacology +8

Pyridazinoquinolinetriones as NMDA Glycine-Site Antagonists with Oral Antinociceptive Activity in a Model of Neuropathic Pain

Thomas M. Bare, Dean G. Brown, Carey L. Horchler et al. · Journal of Medicinal Chemistry · 2007 · 15 citations

Medicine, Neuroscience, Pharmacology +17

Fragment-assisted hit investigation involving integrated HTS and fragment screening: Application to the identification of phosphodiesterase 10A (PDE10A) inhibitors

Jeffrey Varnes, Stefan Geschwindner, Christopher R. Holmquist et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 10 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

A highly potent series of fluoroalkyl benzoxazine pyridine-N-oxide potassium channel openers

Keith C. Russell, F.J. Brown, Paul J. Warwick et al. · Bioorganic & Medicinal Chemistry Letters · 1993 · 10 citations

Medicine, Medicinal Chemistry, Pharmacology +11